Add to watchlist
$451.81
Last updated:06/15/2021
ILMN: NASDAQ
Illumina, Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology,… Show more

P/E ratio
105.56x
vs. 80.65x forward

Price is 105.56x times more than EPS $4.28 which eaquals $451.81

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
726M
826M
+13.77%
1.002B
+21.31%
656M
-34.53%
Cashflow
Sum up money going in and out company
875M
1.142B
+30.51%
1.051B
-7.97%
1.08B
+2.76%
Total liabilities
All combined debts and obligations
2.508B
3.201B
+27.63%
2.703B
-15.56%
2.891B
+6.96%
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 26 ETFs that include this stock
Company profile
CEO
Mr. Francis A. deSouza
Market capitalization
Mega (65.50B)
ILMN price history
Loading price stock history...